[news] May 3rd Beijing reporting network (public network) of traditional Chinese medicine is a treasure of the Chinese nation, Chinese recent intensive introduction of Chinese medicine industry support policies, National Health total cost from the current 3 trillion yuan rose to 8 trillion yuan in 2020, the scale of Chinese medicine industry in 2020 will reach 3 trillion to 4 trillion (RMB). However, subject to the industry and the degree of standardization is not high, the overall level of Chinese herbal medicine and Chinese herbal medicine industry is uneven, a direct impact on the long-term development of China's traditional Chinese medicine.

China Chinese medicine industry chain including upstream planting, breeding, acquisition, processing, processing of Chinese herbal medicine, Chinese medicine, Chinese medicine hospital, the downstream enterprises such as pharmacy, Chinese herbal medicine is a key point in the industrial chain.

Market expansion opportunities: the establishment of uniform standards

In recent years, "the people's Republic of China", "Chinese medicine pharmaceutical development strategic plan (2016-2030)", "health" Chinese 2030 "plan", "Chinese Chinese medicine" white paper issued a number of specially designed for Chinese medicine release policies and regulations part highlights the national attention to the development of traditional Chinese medicine.

In the State Food and Drug Administration and CFDA smeri invited Chinese companies to jointly promote the mainstream of Chinese herbal medicine industry development and supervision of project "to start the meeting, CFDA Southern Medicine Economic Research Institute, Lin Jianning, Chinese of Chinese herbal medicine industry has a long history but there are many development bottlenecks, the first is: Traditional Chinese medicine records in the Warring States period, but the split complex, including traditional Chinese medicine, herbal medicine, Chinese medicine granules and broken pieces of fine pieces, ultra-fine powder, precise boiled powder decoction pieces diversified; second is the industry concentration is low, the overall small pieces industry production enterprises, Pyramid distribution industry, and small enterprises accounted for the majority, but fierce competition.

The third is the loss of high-end resources, the current agricultural and sideline products in the form of cross regional planting makes some varieties of poor quality. Of more concern is that because of the difference of regional difference of Chinese herbal medicine resources and quality, industry standard depends on more subjective factors, need to further strengthen the unity of Chinese herbal medicine standards, inspection standards improve, to further promote the quality specification of Chinese herbal medicine; four is the lack of innovation in the industry, the direction of fuzzy.

On the one hand, the lack of raw materials and the shortage of resources, the utilization rate is low; on the other hand, the traditional Chinese medicine industry technology can not meet the needs of clinical treatment, disease prevention, health care, multi-level functional requirements. Lin Jianning said, is to adhere to the traditional tunnel or another way to monitor how to deal with changes in how to regulate the management to promote the healthy development of the industry, which is the focus of this research.

Traditional Chinese medicine grafting: using traditional and modern technology

According to the state of the traditional Chinese medicine industry positioning, in 2020 the Chinese medicine industry volume will reach three trillion - - four trillion. The National Bureau of statistics data show that in 2016 the Chinese herbal medicine industry sales revenue 192 billion 200 million yuan, in the pharmaceutical industry accounted for the lowest (6.5%), but the growth rate is the fastest (13.1%), higher than the overall growth of the pharmaceutical economy, showing a good momentum of development.

The demand for traditional Chinese medicine, especially the botanical medicine, has been growing rapidly in recent years. The international market has reached 40 billion US dollars, and has grown at a rate of nearly $20% per year. At present, there are 4 billion people use Chinese herbal medicine products, accounting for the world's total population of 80%.

Vice president of Chinese Medicine Association and director of Chinese herbal medicine Specialized Committee Zhang Shichen said that the establishment of the standard system of Chinese herbal medicine production process, Chinese standardization of Chinese herbal medicine, on the basis of inheriting the tradition into the modern development of science and technology innovation. He pointed out that in the traditional Chinese medicine system, China does not completely abandon the old things, to have a national self-confidence.

State Food and Drug Administration of drug registration division director Li Jiangning introduction, in 2016 the Chinese herbal medicine industry profits 14 billion yuan, an increase of 13.3%, accounting for the pharmaceutical industry's total profit of 4.6%. Chinese Herbal Pieces industry sales compound growth rate of 21.7%, sales accounted for up to 6.5%, the industry status has been steadily improved.

He believes that no matter from the active degree of the industrial scale or industry perspective, traditional Chinese medicine industry, especially the development of safety level of quality and level of development of Chinese herbal medicine greatly affects the development level of the whole pharmaceutical industry and residents medication.

At present, the State Food and Drug Administration drug approval system reform is to borrow the opportunity, improve the efficiency of drug registration review, for the introduction of drug registration management measures; in addition, is to further standardize the management of TCM formula granule, has completed the document report to the State Council; in addition is the lead organization national processing standard of traditional Chinese medicines preparation. In this China Chinese herbal medicine is the first time in the history, the organization currently has completed the first part of the Pharmacopoeia Committee of the drafting work, and in the Pharmacopoeia Commission website announced to the public.